Mar Martín-Perez

Pharmacoepidemiology and Pharmacovigilance Division. Spanish Agency of Medicines and Medical Devices (AEMPS). Madrid, Spain, Spain

Poster(s):

• (001) Evaluation Of The Potential Rebound Effect Of Denosumab Discontinuation: A Comparative Study Of Five Different Types Of Antiosteoporotic Medications
  Sunday, August 27, 2023

  8:00 AM – 1:30 PM ADT

• (079) Vaccines effectiveness against hospitalizations ‘for’ and ‘with’ COVID-19, after clinical histories review
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (090) Validation of severe COVID-19 information recorded in BIFAP
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (A27) Incidence of COVID-19 disease severity in a cohort of 4.4 million Italian and Spanish children from 6 healthcare databases
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (B07) Exploring Real-life Persistence with Denosumab (Prolia®): A 7-year-follow-up Study In Spain
  Saturday, August 26, 2023

  8:00 AM – 6:00 PM ADT